Medicare Enrolled
Dr. Stephen Hurlbut, M.D.
Neurology · Bedford, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hurlbut from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hurlbut?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hurlbut
Dr. Stephen Hurlbut is a neurology specialist in Bedford, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Hurlbut performed 1,443 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Hurlbut received a total of $6,399 from 55 pharmaceutical and/or device companies across 351 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hurlbut is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 23% volume in TX
$6,399 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,443
Medicare services
Top 23% in TX for neurology
Not available
Unique patients (not deduplicated)
$73
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
568 | $85 | $323 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
222 | $56 | $218 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
217 | $16 | $67 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
132 | $50 | $215 |
| Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth | 62 | $99 | $348 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
54 | $75 | $325 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
47 | $89 | $342 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
41 | $238 | $727 |
| Telehealth consultation, emergency department or initial inpatient, 70+ minutes A telehealth consultation for a patient in the emergency department or as an initial inpatient visit. The service involves communicating with the patient for 70 minutes or more. |
28 | $142 | $514 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
21 | $106 | $444 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
20 | $96 | $455 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
16 | $62 | $238 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
15 | $90 | $500 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
24.2% high complexity
2.8% medium
73.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,399
Total received (2018-2024)
Avg $914/year across 7 years
Top 35% in TX for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
351
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,512
2023
$1,281
2022
$1,067
2021
$49
2020
$131
2019
$1,005
2018
$1,354
Payments by company (2024)
ABBVIE INC.
$465
EMD Serono, Inc.
$183
Lilly USA, LLC
$175
TG Therapeutics, Inc.
$106
SCILEX PHARMACEUTICALS INC.
$63
Amneal Pharmaceuticals LLC
$63
UCB, Inc.
$58
Teva Pharmaceuticals USA, Inc.
$52
Novartis Pharmaceuticals Corporation
$48
Eisai Inc.
$43
PFIZER INC.
$38
Biogen, Inc.
$33
Ipsen Biopharmaceuticals, Inc
$28
Grifols USA, LLC
$23
Harmony Biosciences Llc
$23
GE HEALTHCARE
$21
CSL Behring
$21
Amgen Inc.
$19
Abbott Laboratories
$17
LivaNova USA, Inc.
$17
Nevro Corp.
$16
Top 3 companies account for 54.5% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,370
Teva Pharmaceuticals USA, Inc.
$540
EMD Serono, Inc.
$329
Biogen, Inc.
$313
GENZYME CORPORATION
$292
Genentech USA, Inc.
$282
Supernus Pharmaceuticals, Inc.
$278
Sunovion Pharmaceuticals Inc.
$263
Lilly USA, LLC
$238
UCB, Inc.
$234
Amgen Inc.
$208
Novartis Pharmaceuticals Corporation
$191
CSL Behring
$135
PFIZER INC.
$124
ACADIA Pharmaceuticals Inc
$112
TG Therapeutics, Inc.
$106
Akcea Therapeutics, Inc.
$96
Biohaven Pharmaceutical Holding Company Ltd.
$69
Grifols USA, LLC
$66
SCILEX PHARMACEUTICALS INC.
$63
Amneal Pharmaceuticals LLC
$63
Neurocrine Biosciences, Inc.
$62
Medtronic USA, Inc.
$61
US WorldMeds, LLC
$60
Alexion Pharmaceuticals, Inc.
$60
Eisai Inc.
$58
Allergan Inc.
$55
Egalet US Inc
$43
Adamas Pharmaceuticals, Inc.
$41
Collegium Pharmaceutical, Inc.
$40
Abbott Laboratories
$40
GE HEALTHCARE
$38
LivaNova USA, Inc.
$36
Mallinckrodt Enterprises LLC
$34
Ipsen Biopharmaceuticals, Inc
$28
Octapharma USA, Inc.
$27
Harmony Biosciences LLC
$25
Avion Pharmaceuticals
$25
IDORSIA PHARMACEUTICALS US INC
$23
Harmony Biosciences Llc
$23
Horizon Therapeutics plc
$22
Validus Pharmaceuticals LLC
$21
Promius Pharma LLC
$19
Jazz Pharmaceuticals Inc.
$19
Neurelis, Inc.
$18
SK Life Science, Inc.
$17
JAZZ PHARMACEUTICALS INC.
$17
Boston Scientific Corporation
$17
Nevro Corp.
$16
AbbVie Inc.
$16
Allergan, Inc.
$15
GE Healthcare
$15
Arbor Pharmaceuticals, Inc.
$13
Assertio Therapeutics, Inc.
$13
ARBOR PHARMACEUTICALS, INC.
$12
Top 3 companies account for 35.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AJOVY · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Actemra · Aimovig · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Briviact · COPAXONE · Cambia · DUOPA · Dhivy · Dysport · ELYXYB - CELECOXIB · ELYXYB - celecoxib · EMGALITY · Equetro · Fycompa · GILENYA · GOCOVRI · Gamunex-C · Hizentra · Horizant · INFINITY · INGREZZA · KESIMPTA · KISUNLA · LEADPOINT · LEMTRADA · LYRICA · Leqembi · MAYZENT · MYOBLOC · Mavenclad · NUPLAZID · NURTEC ODT · Neupro · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS 50MG CAPSULES 30 · Ocrevus · PANZYGA · Privigen · QULIPTA · QUVIVIQ · RYTARY · Rebif · SOLIRIS · SPRIX · SUNOSI · Senza · TECFIDERA · TEGSEDI · TROKENDI XR · TYSABRI · UBRELVY · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VRAYLAR · VYALEV · Vercise · Vimpat · WAKIX · Xyrem · ZEVO · ZTLido · Zembrace
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
238
County median income
$81,905
Nearest hospital to ZIP centroid (approximate)
TEXAS HEALTH HARRIS METHODIST HURST-EULESS-BEDFORD
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hurlbut is a clinical cardiology specialist, with above-average Medicare volume (top 23% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hurlbut experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Hurlbut performed 568 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Hurlbut receive payments from pharmaceutical companies?
Yes. Dr. Hurlbut received a total of $6,399 from 55 companies across 351 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hurlbut's costs compare to other neurologists in Bedford?
Dr. Hurlbut's average Medicare payment per service is $73. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hurlbut) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Bedford
Browse neurologists in Bedford ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in TX
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in TX
Which TX neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
EMD Serono, Inc. Payments to Doctors
See all physicians who received payments from EMD Serono, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology